Affiliation:
1. Cleveland Clinic, Digestive Diseases and Surgery and Institute General Surgery Cleveland Ohio USA
2. Department of Surgical Oncology Edward‐Elmhurst Health Elmhurst Illinois USA
3. Moffitt Cancer Center GI Oncology Program Tampa Florida USA
4. Cleveland Clinic Digestive Diseases and Surgery and Institute Colorectal Surgery Cleveland Ohio USA
Abstract
AbstractIntroductionA minimum lymph node harvest (LNH) of 12 is the current standard for appropriate nodal staging in resectable rectal cancer. However, the rise of neoadjuvant chemoradiation (NCRT) and total neoadjuvant therapy (TNT) has been associated with decreasing number of LNH. We hypothesize that as tumor response to neoadjuvant therapy increases, the optimum for LNH to achieve appropriate nodal staging should decrease.MethodsPatients with clinical stage III rectal adenocarcinoma who underwent NCRT/TNT followed by resection were identified from the National Cancer Database. A JoinPoint regression analysis was used to determine the LNH for each tumor regression grade (TRG) category beyond which the rate of positive nodes does not significantly change.ResultsThirteen thousand four hundred and twenty‐six patients met inclusion criteria. Of these, 2406 (17.9%) achieved TRG 0 or ypT0 and 8210 (61.2%) achieved ypN0. Collectively, 2043 patients (15.2%) were reported to have a pathologic complete response (ypT0 ypN0). Positive pathologic nodes were found in 15%, 23%, 31%, 54%, and 53% as ypT stage increased from ypT0 to ypT4, respectively. Similarly, ypN+ rates were 15%, 36%, 41%, and 55% in TRG 0–3. No JoinPoint was identified for TRG 0, whereas inflection points were found at 6–10 nodes for TRG1 (p = 0.002) and TRG 2 (p = 0.016), and at 11–15 nodes for TRG 3.ConclusionThe benchmark of retrieving 12 nodes in resectable stage III rectal cancer is not consistently achieved after NCRT/TNT. We demonstrate that the LNH requirement to establish accurate pathologic nodal staging can vary depending on the tumor response to neoadjuvant therapies.
Subject
Oncology,General Medicine,Surgery
Reference28 articles.
1. National Comprehensive Cancer Network.Rectal Cancer Practice Guidelines. (version 3.2023). National Comprehensive Cancer Network;2023.
2. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes
3. Total Mesorectal Excision Technique—Past, Present, and Future
4. Total Mesorectal Excision: What Are We Doing?
5. National Comprehensive Cancer Network.Rectal Cancer Practice Guidelines. (version 4.2023). National Comprehensive Cancer Network; 2023.https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf